<em>Pseudomonas aeruginosa</em>: Recent Advances in Vaccine Development
<i>Pseudomonas aeruginosa</i> is an important opportunistic human pathogen. Using its arsenal of virulence factors and its intrinsic ability to adapt to new environments, <i>P. aeruginosa</i> causes a range of complicated acute and chronic infections in immunocompromised indi...
Main Authors: | Matthew Killough, Aoife Maria Rodgers, Rebecca Jo Ingram |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-07-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/7/1100 |
Similar Items
-
Polymicrobial Interactions in the Cystic Fibrosis Airway Microbiome Impact the Antimicrobial Susceptibility of <i>Pseudomonas aeruginosa</i>
by: Emma Reece, et al.
Published: (2021-07-01) -
Detection of Morphotyping Characteristics Identification Antibiotic Resistance of Pseudomonas aeruginosa Isolated from Patients with Cystic Fibrosis
by: Hossein Fazeli, et al.
Published: (2012-03-01) -
THE PREVALENCE OF PSEUDOMONAS AERUGINOSA STRAINS IN INFANTS WITH CYSTIC FIBROSIS WITHIN A HOSPITAL IN NORTH EASTER OF ROMANIA
by: Oana Alexandra Ciocan, et al.
Published: (2016-11-01) -
Preclinical Development of a Bacteriophage Cocktail for Treating Multidrug Resistant <em>Pseudomonas aeruginosa</em> Infections
by: Sophie Camens, et al.
Published: (2021-09-01) -
<i>Pseudomonas aeruginosa</i>: Infections, Animal Modeling, and Therapeutics
by: Stephen J. Wood, et al.
Published: (2023-01-01)